Hand dermatitis: Review of clinical features and treatment options

Seminars in Cutaneous Medicine and Surgery

Volumn 32, Issue 3, 2013, Pages 147-157

  Golden, Spring ^a   Shaw, Tatyana ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Allergic contact dermatitis; Atopic dermatitis; Chronic hand dermatitis; Dyshidrotic dermatitis; Frictional hand dermatitis; Hand dermatitis; Hyperkeratotic dermatitis; Irritant contact dermatitis; Nummular dermatitis; Pompholyx; Psoriasiform hand dermatitis; Vesicular dermatitis

Indexed keywords

ALITRETINOIN; ALLERGEN; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; ETRETIN; HAND SANITIZER; METHOTREXATE; MOMETASONE FUROATE; MYCOPHENOLATE MOFETIL; PETROLATUM; PIMECROLIMUS; PREDNISONE; STEROID; TACROLIMUS; DERMATOLOGICAL AGENT;

ACNE; ARTICLE; ATOPIC DERMATITIS; BONE MARROW SUPPRESSION; CATARACT; CHRONIC VESICULAR DERMATITIS; CLINICAL FEATURE; CREAM; DERMATITIS; DERMATOMYOSITIS; DERMATOPHYTOSIS; DIFFERENTIAL DIAGNOSIS; DRUG CARCINOGENICITY; FRICTIONAL DERMATITIS; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HAND; HAND DERMATITIS; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERKERATOSIS; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; HYPOMAGNESEMIA; INFECTION; IRRITANT DERMATITIS; LICHEN PLANUS; LIVER TOXICITY; LUNG FIBROSIS; LYMPHOMA; MEDICAL HISTORY; MOUTH ULCER; MYCOSIS FUNGOIDES; NEPHROTOXICITY; NUMMULAR DERMATITIS; OINTMENT; OPPORTUNISTIC INFECTION; OSTEOPOROSIS; PATHOGENESIS; PHOTOTHERAPY; PHYSICAL EXAMINATION; PITYRIASIS RUBRA PILARIS; PNEUMONIA; POMPHOLYX; PSORIASIS; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); ROSACEA; SCABIES; SKIN ALLERGY; SKIN ATROPHY; SKIN CARE; SKIN TUMOR; STRIA; SYSTEMIC THERAPY; TELANGIECTASIA; TERATOGENICITY; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; XEROSIS; HAND DERMATOSES; HAND WASHING; HEALTH; INCIDENCE; OCCUPATIONAL EXPOSURE; PATCH TEST; PROCEDURES;

DERMATOLOGIC AGENTS; GLOBAL HEALTH; HAND DERMATOSES; HAND HYGIENE; HUMANS; INCIDENCE; OCCUPATIONAL EXPOSURE; PATCH TESTS;

EID: 84891521665     PISSN: 10855629     EISSN: 15580768     Source Type: Journal    
DOI: 10.12788/j.sder.0027     Document Type: Article

References (47)

1. Meding B, Jarvholm B. Hand eczema in Swedish adults-changes in prevalence between 1983 and 1996. J Invest Dermatol. 2002;118(4): 719-723
2. Cvetkovski RS, Zachariae R, Jensen H, Olsen J, Johansen JD, Agner T. Quality of life and depression in a population of occupational hand eczema patients. Contact Dermatitis. 2006;54(2):106-111
3. Veien NK, Hattel T, Laurberg G. Hand eczema: causes, course, and prognosis I. Contact Dermatitis. 2008;58(6):330-334
4. Dooms-Goossens A, Drieghe J, Dooms M. A computer system for contact dermatitis: graphical representation of data. Ann Acad Med Singapore. 1990;19(5):687-690
5. Nilsson E. Individual and environmental risk factors for hand eczema in hospital workers. Acta Derm Venereol Suppl (Stockh). 1986;128:1-63
6. Smit HA, Burdorf A, Coenraads PJ. Prevalence of hand dermatitis in different occupations. Int J Epidemiol. 1993;22(2):288-293
7. Diepgen TL, Agner T, Aberer W, et al. Management of chronic hand eczema. Contact Dermatitis. 2007;57(4):203-210
8. Coenraads PJ. Hand eczema. N Engl J Med. 2012;367(19):1829-1837
9. Simpson EL, Hanifin JM. Atopic dermatitis. Med Clin North Am. 2006; 90(1):149-167, ix
10. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol. 2011;131(1):67-73
11. Asher MI, Montefort S, Bjorkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537):733-743
12. Coenraads PJ, Diepgen TL. Risk for hand eczema in employees with past or present atopic dermatitis. Int Arch Occup Environ Health. 1998;71(1): 7-13
13. Simpson EL, Thompson MM, Hanifin JM. Prevalence and morphology of hand eczema in patients with atopic dermatitis. Dermatitis. 2006; 17(3):123-127
14. Tresukosol P, Swasdivanich C. Hand contact dermatitis in hairdressers: clinical and causative allergens, experience in Bangkok. Asian Pac J Allergy Immunol. 2012;30(4):306-312
15. Alavi A, Skotnicki S, Sussman G, Sibbald RG. Diagnosis and treatment of hand dermatitis. Adv Skin Wound Care. 2012;25(8):371-380; quiz 381-372
16. Kedrowski DA, Warshaw EM. Hand dermatitis: a review of clinical features, diagnosis, and management. Dermatol Nurs. 2008;20(1):17-25; quiz 26
17. Warshaw E, Lee G, Storrs FJ. Hand dermatitis: a review of clinical features, therapeutic options, and long-term outcomes. Am J Contact Dermat. 2003;14(3):119-137
18. Sun CC, Guo YL, Lin RS. Occupational hand dermatitis in a tertiary referral dermatology clinic in Taipei. Contact Dermatitis. 1995;33(6): 414-418
19. Pratt MD, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch-test results, 2001-2002 study period. Dermatitis. 2004;15(4):176-183
20. Warshaw EM, Belsito DV, Taylor JS, et al. North American Contact Dermatitis Group patch test results: 2009 to 2010. Dermatitis. 2013; 24(2):50-59
21. Centers for Disease Control (CDC). Leading work-related diseases and injuries-United States. MMWR Morb Mortal Wkly Rep. 1986;35(12): 185-188
22. Nassif A, Chan SC, Storrs FJ, Hanifin JM. Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis. Arch Dermatol. 1994; 130(11):1402-1407
23. Menne T, Hjorth N. Frictional contact dermatitis. Am J Ind Med. 1985; 8(4-5):401-402
24. Vermeer MH, Bruynzeel DP. Mouse fingers, a new computer-related skin disorder. J Am Acad Dermatol. 2001;45(3):477
25. Ibler KS, Agner T, Hansen JL, Gluud C. The Hand Eczema Trial (HET): Design of a randomised clinical trial of the effect of classification and individual counselling versus no intervention among health-care workers with hand eczema. BMC Dermatol. 2010;10:8
26. Menné T, Johansen JD, Sommerlund M, Veien NK. Danish Contact Dermatitis Group. Hand eczema guidelines based on the Danish guidelines for the diagnosis and treatment of hand eczema. Contact Dermatitis. 2011;65(1):3-12
27. Veien NK, Olholm Larsen P, Thestrup-Pedersen K, Schou G. Longterm, intermittent treatment of chronic hand eczema with mometasone furoate. Br J Dermatol. 1999;140(5):882-886
28. Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for the use of topical glucocorticosteroids. American Academy of Dermatology. J Am Acad Dermatol. 1996;35(4):615-619
29. Belsito DV, Fowler JF Jr., Marks JG Jr., et al; Multicenter Investigator Group. Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis. 2004;73(1):31-38
30. Schnopp C, Remling R, Möhrenschlager M, Weigl L, Ring J, Abeck D. Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J Am Acad Dermatol. 2002;46(1):73-77
31. Krejci-Manwaring J, McCarty MA, Camacho F, et al. Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper. J Drugs Dermatol. 2008;7(7):643-646
32. Rosén K, Mobacken H, Swanbeck G. Chronic eczematous dermatitis of the hands: a comparison of PUVA and UVB treatment. Acta Derm Venereol. 1987;67(1):48-54
33. Sezer E, Etikan I. Local narrowband UVB phototherapy vs. local PUVA in the treatment of chronic hand eczema. Photodermatol Photoimmunol Photomed. 2007;23(1):10-14
34. Fairris GM, Mack DP, Rowell NR. Superficial X-ray therapy in the treatment of constitutional eczema of the hands. Br J Dermatol. 1984;111(4): 445-449
35. Walling HW, Swick BL, Storrs FJ, Boddicker ME. Frictional hyperkeratotic hand dermatitis responding to Grenz ray therapy. Contact Dermatitis. 2008;58(1):49-51
36. Edwards EK, Jr., Edwards EK. Grenz ray therapy [published correction appears in Int J Dermatol. 1990;29(4);257]. Int J Dermatol. 1990; 29(1):17-18
37. Ruzicka T, Lynde CW, Jemec GB, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol. 2008;158(4):808-817
38. Bissonnette R, Worm M, Gerlach B, et al. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema. Br J Dermatol. 2010;162(2):420-426
39. Schmitt J, Schäkel K, Schmitt N, MeurerM.Systemic treatment of severe atopic eczema: a systematic review. Acta Derm Venereol. 2007;87(2):100-111
40. Granlund H, Erkko P, Eriksson E, Reitamo S. Comparison of cyclosporine and topical betamethasone-17, 21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol. 1996;76(5):371-376
41. Granlund H, Erkko P, Reitamo S. Long-term follow-up of eczema patients treated with cyclosporine. Acta Derm Venereol. 1998;78(1):40-43
42. Pickenacker A, Luger TA, Schwarz T. Dyshidrotic eczema treated with mycophenolate mofetil. Arch Dermatol. 1998;134(3):378-379
43. Semhoun-Ducloux S, Ducloux D, Miguet JP. Mycophenolate mofetilinduced dyshidrotic eczema. Ann Intern Med. 2000;132(5):417
44. Egan CA, Rallis TM, Meadows KP, Krueger GG. Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol. 1999;40(4):612-614
45. Scerri L. Azathioprine in dermatological practice. An overview with special emphasis on its use in non-bullous inflammatory dermatoses. Adv Exp Med Biol. 1999;455:343-348
46. Ogden S, Clayton TH, Goodfield MJ. Recalcitrant hand pompholyx: variable response to etanercept. Clin Exp Dermatol. 2006;31(1):145-146
47. Wolverton SE. Comprehensive dermatologic drug therapy. 3rd ed. Edinburgh: Saunders/Elsevier; 2013